Edition:
United States

Kala Pharmaceuticals Inc (KALA.OQ)

KALA.OQ on NASDAQ Stock Exchange Global Select Market

10.75USD
21 Sep 2018
Change (% chg)

$-0.21 (-1.92%)
Prev Close
$10.96
Open
$10.96
Day's High
$11.05
Day's Low
$10.63
Volume
200,462
Avg. Vol
52,151
52-wk High
$24.46
52-wk Low
$10.34

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.595
Mar '18 0.00 -0.460
FY 2017 Dec '17 0.00 -1.606
Sep '17 0.00 -0.564
Jun '17 0.00 -0.472
Mar '17 0.00 -0.419
FY 2016 Dec '16 0.00 -0.361
Sep '16 0.00 -0.415
Jun '16 0.00 -0.423
Mar '16 0.00 -0.226
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 3 0.00 0.00 0.00 5.85
Quarter Ending Dec-18 3 0.00 0.00 0.00 6.50
Year Ending Dec-18 4 0.00 0.00 0.00 14.90
Year Ending Dec-19 5 22.81 36.00 14.00 61.63
Earnings (per share)
Quarter Ending Sep-18 4 -0.62 -0.60 -0.63 -0.50
Quarter Ending Dec-18 4 -0.64 -0.54 -0.70 -0.56
Year Ending Dec-18 4 -2.31 -2.19 -2.38 -1.73
Year Ending Dec-19 5 -2.67 -1.21 -3.68 -1.79
LT Growth Rate (%) 1 -62.10 -62.10 -62.10 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 108.33 32.69
P/E High - Last 5 Yrs. -- 278.75 47.23
P/E Low - Last 5 Yrs. -- 97.93 24.79
Beta -- 0.61 0.87
Price to Sales (TTM) -- 110.30 6.46
Price to Book (MRQ) 3.88 12.48 3.90
Price to Tangible Book (MRQ) 3.90 18.90 5.96
Price to Cash Flow (TTM) -- 62.41 23.20
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.69
Dividend Yield - 5 Year Avg -- 0.21 1.45
Dividend 5 Year Growth Rate -- 2.62 -5.70
Payout Ratio(TTM) -- 5.94 46.56

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 175.09 8.38
Sales (TTM) vs TTM 1 Yr. Ago -- 92.96 6.69
Sales - 5 Yr. Growth Rate -- 24.50 7.56
EPS (MRQ) vs Qtr. 1 Yr. Ago -26.12 283.36 25.56
EPS (TTM) vs TTM 1 Yr. Ago -93.52 -- --
EPS - 5 Yr. Growth Rate -- 23.65 7.60
Capital Spending - 5 Yr. Growth Rate -- 38.57 8.37

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.63 2.19
Current Ratio (MRQ) 9.78 5.49 2.97
LT Debt to Equity (MRQ) 26.58 15.10 11.24
Total Debt to Equity (MRQ) 29.03 18.62 14.06
Interest Coverage (TTM) -22.34 -215.83 35.11

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.03 54.67
Gross Margin - 5 Yr. Avg. -- 52.71 53.30
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -177.00 15.88
Operating Margin (TTM) -- -607.80 3.65
Operating Margin - 5 Yr. Avg. -- -190.63 11.00
Pre-Tax Margin (TTM) -- -604.88 3.97
Pre-Tax Margin - 5 Yr. Avg. -- -193.42 11.19
Net Profit Margin (TTM) -- -599.69 0.70
Net Profit Margin - 5 Yr. Avg. -- -191.17 7.52
Effective Tax Rate (TTM) -- 11.60 20.44
Effective Tax Rate - 5 Yr. Avg. -- 19.16 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 5,335,375 714,979,821
Net Income/Employee (TTM) -1,280,595 -5,831,664 82,568,832
Receivable Turnover (TTM) -- 4.20 5.01
Inventory Turnover (TTM) -- 2.06 3.61
Asset Turnover (TTM) 0.00 0.38 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -76.31 0.80 9.75
Return on Assets - 5 Yr. Avg. -- 2.53 10.91
Return on Investment (TTM) -88.62 1.50 12.72
Return on Investment - 5 Yr. Avg. -- 2.04 14.03
Return on Equity (TTM) -- 0.19 14.85
Return on Equity - 5 Yr. Avg. -- -2.23 15.38
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -329.25 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Kala Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -16.21 -17.78 41 74
13 Week -21.70 -26.38 80 56
26 Week -37.10 -44.43 59 45
52 Week -47.69 -55.35 61 88
YTD -41.86 -46.94 61 80
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 86.11%
# of Holders: 101
Total Shares Held: 21,175,670
3 Mo. Net Change: -1,072,548
# New Positions: 10
# Closed Positions: 17
# Increased Positions: 36
# Reduced Positions: 52
# Net Buyers: -16
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.